Dr. Rahil Shahzad
Clinical Product Analyst
Dr. Rahil Shahzad's educational background lies in biomedical engineering and medical image analysis, having obtained an MSc from Warwick University, UK, and a PhD from Technical University Delft, Netherlands. With a career spanning over 15 years in radiology and close to 50 publications in esteemed conferences and journals, Dr. Shahzad has navigated roles in academia and healthcare industries. Presently, he holds the position of Clinical Product Analyst at Blackford Analysis.
Dr. Vitor Hugo Pereira
Chief Medical Officer
Vitor Hugo Pereira (VHP) is a cardiologist specialized in cardiovascular imaging, with a particular passion for Cardiovascular Magnetic Resonance (cMRI). VHP has dedicated his post-PhD career to clinical research. He is the Chief Medical Officer at Ai4Medical Imaging, a deep tech company that develops machine learning algorithms for the automatic interpretation of cMRI. Their flagship product, Ai4CMR, is a cloud-native AI-based software designed to be easily integrated into the clinical workflow to facilitate the work of cMRI experts.
Dr. Morteza Naghavi
Founder
Dr. Naghavi is an innovative physician scientist, entrepreneur, and life science executive with over two decades of leadership experience in academia and industry. Dr. Naghavi is internationally recognized for his medical inventions and the SHAPE initiative, a nonprofit organization focused on innovative solutions for the eradication of heart attacks. Dr. Naghavi is currently leading a major initiative supported by world renowned cardiologist Dr. Valentin Fuster and other leaders in CVD towards securing Medicare reimbursement for coronary calcium score.
Dr. Ieva Kazukauskiene
Chief Medical Officer
Ieva is a renowned cardiologist specializing in echocardiography. Her field of research focuses on non-ischemic dilated cardiomyopathy (DCM) and echocardiography. Ieva is also teaching at one of the best and oldest medical universities in Europe.
Dr. Orit Wimpfheimer
Chief Medical Officer
Orit Wimpfheimer is Chief Medical Officer of Nanox, a NASDAQ traded company focusing on a both a medical device, the Nanox ARC, an tomographic imaging device using proprietary carbon nano-technology and Nanox AI which creates artificial intelligence products to facilitate population health screening from routine CT scans. Having received her MD from Albert Einstein College of Medicine, she then did her diagnostic radiology residency and fellowship at Columbia Presbyterian Medical Center. In 2022, she was a co-founder of Remote Radiology, a boutique teleradiology company based in Israel. In 2019, she joined Zebra Medical Vision as clinical director and then chief medical officer, working on multi-modality imaging AI. In 2022, Nanox bought Zebra forming one unified company.
Dr. Yoran Hummel
President & Co-founder
Yoran Hummel obtained a bachelor degree in cardiac physiology 2004 specializing in echocardiography while working in the University Medical Center Groningen (Netherlands). Here he developed a keen interest in novel techniques and research, now leading up to > 50 publications in peer reviewed journals on cardiotoxicity, genetics and point-of-care echo, but always with Cardiac function/failure as common denominator. Founding and leading Groningen Imaging Core Laboratory in 2009 during the time he had his PhD candidacy. In that period he coordinated all echocardiographic logistics in several large multicenter global clinical trials.He received his PhD from the University of Groningen on the topic of echocardiography and the detection of subtle cardiac damage and Heart Failure in 2012.
